Aliskiren/amlodipine/hydrochlorothiazide

The drug combination aliskiren/amlodipine/hydrochlorothiazide (INNs, trade name Amturnide) is an antihypertensive approved in the United States on 21 December 2010.[1]

Aliskiren/amlodipine/hydrochlorothiazide
Combination of
AliskirenRenin inhibitor
AmlodipineCalcium channel blocker
HydrochlorothiazideDiuretic
Clinical data
Trade namesAmturnide
AHFS/Drugs.comConsumer Drug Information
License data
Pregnancy
category
  • US: N (Not classified yet)
    Routes of
    administration    		Oral
    ATC code
    Legal status
    Legal status
    Identifiers
    CAS Number
    PubChem CID
    Chemical and physical data
    FormulaC57H86Cl2N8O15S2
    Molar mass1258.38 g·mol−1
    3D model (JSmol)
      (verify)

    References
    1. Amturnide approval letter. U.S. Food and Drug Administration (FDA).
    • "Amturnide". Drug Information Portal. U.S. National Library of Medicine.
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.